metronidazole
Commercial- Indications
- Bacterial vaginosis
Company intelligence / Profile preview
Solaris Pharma Corporation
Bridgewater, New Jersey, United Statessolaris-pharma.com ↗
- Ownership
- Private
- Employees
- ~36
- Development stage
- Commercial
01
Overview
Solaris Pharma has successfully developed and received approval for multiple products including Tazarotene Gel, Clindamycin Phosphate and Tretinoin Gel, Metronidazole Vaginal Gel, Clindamycin Phosphate Gel, Fluocinolone Acetonide Topical Oil, Acyclovir Ointment, and Clobetasol Propionate Cream.
- Therapeutic areas
- Dermatology
- Modalities
- TopicalsSolutionsSuspensionsOphthalmic productsSterile productsTablets
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Solaris Pharma Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solaris Pharma Corporation.